Singapore markets close in 5 hours 27 minutes

NeuroSense Therapeutics Ltd. (NRSN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.3600+0.0100 (+0.74%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-11,280
-11,280
-12,340
-4,041
-2,828
Depreciation & amortisation
97
97
89
3
3
Stock-based compensation
2,798
2,798
5,105
4,159
2,061
Change in working capital
1,908
1,908
750
273
71
Accounts payable
961
961
459
-16
32
Other working capital
-8,481
-8,481
-7,656
-1,556
-704
Other non-cash items
402
402
-24
791
-2
Net cash provided by operating activities
-8,452
-8,452
-7,586
-1,539
-695
Cash flows from investing activities
Investments in property, plant and equipment
-29
-29
-70
-17
-9
Purchases of investments
-
-
-3,500
0
0
Other investing activities
-3
-3
-20
-
-
Net cash used for investing activities
3,646
3,646
-3,541
-17
-9
Cash flows from financing activities
Debt repayment
-80
-80
-79
0
0
Common stock issued
3,970
3,970
0
9,864
508
Other financing activities
-
-
-
800
-
Net cash used provided by (used for) financing activities
3,895
3,895
3,695
11,902
508
Net change in cash
-903
-903
-7,520
10,364
-196
Cash at beginning of period
3,543
3,543
11,063
699
895
Cash at end of period
2,640
2,640
3,543
11,063
699
Free cash flow
Operating cash flow
-8,452
-8,452
-7,586
-1,539
-695
Capital expenditure
-29
-29
-70
-17
-9
Free cash flow
-8,481
-8,481
-7,656
-1,556
-704